| ECS | Endocannabinoid system |
| eCB | Endocannabinoid |
| AEA | Anandamide, i.e., N-arachidonoylethanolamine |
| 2-AG | 2-arachidonoylglycerol |
| PEA | N-palmitoylethanolamine |
| OEA | N-oleoylethanolamine |
| AA | Arachidonic acid |
| OFP | Orofacial pain |
| VPS | Verbal pain scale |
| HIS | International Headache Society |
| TMD | Temporomandibular disorders (i.e., myofascial or joint pain) |
| DC/TMD | Diagnostic Criteria for Temporomandibular Disorders |
| NVOP | Neurovascular orofacial pain (orofacial migraine), |
| TTH | Tension-type headache |
| PTN | Post-traumatic neuropathy |
| TN | Trigeminal neuralgia |
| PHN | Post-herpetic neuralgia |
| PIFP | Persistent idiopathic facial pain |
| BMS | Burning mouth syndrome |
| HRQoL | Health-related quality of life |
| BMI | Body mass index |